UNIGE document Scientific Article
previous document  unige:97117  next document
add to browser collection
Title

Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial

Authors
Natalucci, Giancarlo
Latal, Beatrice
Sick, Beate
Held, Leonhard
Bucher, Hans Ulrich
Fauchère, Jean-Claude
show hidden authors show all authors [1 - 9]
Collaboration
Published in JAMA (Journal of the American Medical Association). 2016, vol. 315, no. 19, p. 2079-85
Abstract Very preterm infants are at risk of developing encephalopathy of prematurity and long-term neurodevelopmental delay. Erythropoietin treatment is neuroprotective in animal experimental and human clinical studies.
Keywords Child DevelopmentChild, PreschoolDevelopmental Disabilities/prevention & controlDouble-Blind MethodDrug Administration ScheduleErythropoietin/administration & dosageFemaleHumansInfant, NewbornInfant, PrematureIntention to Treat AnalysisMaleNeurodevelopmental Disorders/prevention & controlNeuroprotective Agents/administration & dosageRecombinant Proteins/administration & dosageTreatment Outcome
Identifiers
PMID: 27187300
Full text
Article (Published version) (298 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups L'imagerie cérébrale (184)
Réanimation néonatale en salle d'accouchement (696)
Citation
(ISO format)
NATALUCCI, Giancarlo et al. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial. In: JAMA (Journal of the American Medical Association), 2016, vol. 315, n° 19, p. 2079-85. doi: 10.1001/jama.2016.5504 https://archive-ouverte.unige.ch/unige:97117

210 hits

0 download

Update

Deposited on : 2017-09-27

Export document
Format :
Citation style :